PFE

VALUE TRAP?

Pfizer, Inc.

Healthcare · Rank #141 · Analyzed Oct 18, 2026

$29.58

Current Price

$40.09

Intrinsic Value

+35.5%

Upside/Downside

3.5/10

Score

1.5/5

Quality

Analysis Summary

Valuation Consensus2/2 methods agree

Quality Score1.5/5.0

Framework RatingVALUE TRAP?

Price vs Intrinsic ValueUndervalued by 35.5%

Fair Value Range

Low$30.38

Base (IV)$40.09

High$51.86

Entry Points

Conservative$21.27

Moderate$30.38

Aggressive$28.06

⚠️ Warnings

Cheap (+36%) but low quality (1.5/5) — possible value trap; cheapness may be deserved

Quality & Moat Breakdown

Return on Equity5.0% → 0/1.0

Debt LevelD/E 74 → 0/1.0

Revenue QualityGrowth -11.0%, margin Δ+40.2% +recovery → 0.5/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins6.8% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.